Page last updated: 2024-09-02

tanshinone and Cardiomyopathy, Hypertrophic Obstructive

tanshinone has been researched along with Cardiomyopathy, Hypertrophic Obstructive in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, RJ; Chen, YF; Day, CH; Huang, CY; Lee, NH; Lin, CH; Rajendran, P; Viswanadha, VP; Yang, JJ1
Li, YS; Wang, J; Wang, ZH1

Other Studies

2 other study(ies) available for tanshinone and Cardiomyopathy, Hypertrophic Obstructive

ArticleYear
Tanshinone IIA Inhibits β-Catenin Nuclear Translocation and IGF-2R Activation via Estrogen Receptors to Suppress Angiotensin II-Induced H9c2 Cardiomyoblast Cell Apoptosis.
    International journal of medical sciences, 2017, Volume: 14, Issue:12

    Topics: Abietanes; Angiotensin II; Animals; Apoptosis; beta Catenin; Cardiomyopathy, Hypertrophic; Cell Line; Cell Nucleus; Drugs, Chinese Herbal; Humans; Myocytes, Cardiac; Phosphorylation; Protein Transport; Rats; Receptor, IGF Type 2; Receptors, Estrogen; Salvia miltiorrhiza; Signal Transduction

2017
[Effect of tanshinone II A on angiotensin receptor in hypertrophic myocardium of rats with pressure over-loading].
    Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 2008, Volume: 28, Issue:7

    Topics: Abietanes; Animals; Blood Pressure; Calcium; Cardiomyopathy, Hypertrophic; Disease Models, Animal; Female; Humans; Male; Myocardium; Phenanthrenes; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin

2008